The VGXI cGMP Production Service provides injectable-grade plasmids suitable for human clinical trials and commercial supply. VGXI's patented AIRMIX ® purification technology delivers the highest quality plasmids in the industry with supercoil percentages >99% and final product concentrations from 1 to 15mg/mL.
